Episode 85: John Timar: Former Navy SEAL & CEO of Kill Cliff - A Clean Energy Drink Company
Today Brad speaks with John Timar, former Navy SEAL and CEO at Kill Cliff. Kill Cliff is America's fastest growing clean energy drink company and is the first and largest national brand to launch a CBD beverage. Kill Cliff has donated over $1m to military charities and is an official partner of the Navy SEAL Foundation.
Previously, John was an executive at TerraGo, a venture-backed software company specializing in SaaS and PaaS mobile applications. He also led business development at Eurasia Group, a predictive analytics startup providing global risk information products to subscribers.
John was a founding member of Control Risks GS, Inc, a wholly-owned subsidiary of Control Risks and the fastest growing business unit worldwide.
Listen in as John offers a glimpse into his experience training with the Navy SEALs and the carryovers he sees between the military and the business world. He then does a deep dive into Kill Cliff’s unique story as a company and how they scaled up to become one of the most exciting brands in the beverage sector today.
Topics Discussed:
[01:00] Similarities between being a Navy SEAL and a business owner
[07:04] The hardest part about becoming part of the SEAL teams
[12:12] What separates those who succeed and those who fail in becoming SEALs
[15:39] The dangers that follow your initial success as an entrepreneur
[17:49] An introduction to Kill Cliff
[23:24] Kill Cliff’s appeal
[25:51] Kill Cliff’s unique foray into the beverage sector
[31:03] How John helped investors see the potential in Kill Cliff
[36:44] The value of interdependence among teams
[42:53] Having conversations with investors about the big picture, not just the bottom line
[48:28] Using non-traditional marketing strategies to scale Kill Cliff
[55:06] What’s next for John and Kill Cliff?
Key Quotes by John:
The cornerstone of teamwork is interdependency.
Alignment is a key part of business. It’s part of interdependency, teamwork, and focus.